Cancer data firm funded
Proscia, the startup storing cancer patients' biopsy data in the cloud, has gained a million dollars worth of seed funding.
The Baltimore-based company was started to ramp up the pace of cancer diagnosis and treatment. It aims to help digital pathology by making biopsy images available for annotation and collaboration. Proscia's software brings together machine learning, computer vision and cloud computing, to recognize histological patterns in whole slide images and improve diagnostic precision. It can quantify tissue imagery and data in ways not possible with the microscope and naked eye. The financing was led by Emerald Development Managers, with participation from Robin Hood Ventures, TCP Venture Capital and A-Level Capital. ®